All lobbying filings

ERVIN GRAVES STRATEGY GROUP, LLC

ERVIN GRAVES STRATEGY GROUP, LLC filed a Q3 report for N BRERETON MEDICAL TECHNOLOGIES on October 19, 2026, reporting $20,000 in lobbying income.

Lobbying for N BRERETON MEDICAL TECHNOLOGIES · Medical technology focused on pain management and opioid reduction solutions.

All filings by ERVIN GRAVES STRATEGY GROUP, LLC · Everything N BRERETON MEDICAL TECHNOLOGIES has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Virginia

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Development and use of medical technologies for pain management and opioid dependency treatment, including titration-based methodologies (FenBlock).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.